Literature DB >> 4562949

Lobeline and reduction of cigarette smoking.

G C Davison, R C Rosen.   

Abstract

Mesh：

Substances：

Year:  1972        PMID： 4562949     DOI： 10.2466/pr0.1972.31.2.443

Source DB:  PubMed          Journal:  Psychol Rep        ISSN： 0033-2941


× No keyword cloud information.
  5 in total

1.  Effects of lobeline, a nicotinic receptor ligand, on the cloned Kv1.5.

Authors:  Imju Jeong; Bok Hee Choi; Sang June Hahn
Journal:  Pflugers Arch       Date:  2010-08-24       Impact factor: 3.657

Review 2.  Advances in non-nicotine pharmacotherapy for smoking cessation.

Authors:  L S Covey; M A Sullivan; J A Johnston; A H Glassman; M D Robinson; D P Adams
Journal:  Drugs       Date:  2000-01       Impact factor: 9.546

Review 3.  Lobeline for smoking cessation.

Authors:  Lindsay F Stead; John R Hughes
Journal:  Cochrane Database Syst Rev       Date:  2012-02-15

4.  Lobeline esters as novel ligands for neuronal nicotinic acetylcholine receptors and neurotransmitter transporters.

Authors:  Marhaba Hojahmat; David B Horton; Seth D Norrholm; Dennis K Miller; Vladimir P Grinevich; Agripina Gabriela Deaciuc; Linda P Dwoskin; Peter A Crooks
Journal:  Bioorg Med Chem       Date:  2009-12-06       Impact factor: 3.641

5.  Current and emerging pharmacotherapeutic options for smoking cessation.

Authors:  Kristin V Carson; Malcolm P Brinn; Thomas A Robertson; Rachada To-A-Nan; Adrian J Esterman; Matthew Peters; Brian J Smith
Journal:  Subst Abuse       Date:  2013-05-23
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.